Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07197853) titled 'Clinical Efficacy and Safety of Microwave Ablation Combined With Huaier Granules in Patients With Inoperable Stage IA Non-Small Cell Lung Cancer: A Prospective, Single-Center, Randomized Controlled Clinical Trial' on Sept. 26.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Xin Ye

Condition: Non-small Cell Lung Cancer (NSCLC) Huaier Granules Microwave Ablation

Intervention: Drug: Huaier Granule

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: October ...